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Abstract
 Objective—Inflammation and infection within the central nervous system is initiated during 
primary HIV infection (PHI), but the association of these processes with the integrity of brain 
white matter during PHI is unknown.
 Design—We used diffusion tensor imaging (DTI) in this prospective cross-sectional 
neuroimaging study to determine the extent of white matter involvement in early HIV infection.
 Methods—Antiretroviral-naive PHI (defined as <1 year after infection, n = 62), chronic HIV 
infection (CHI, n = 16), and HIV-uninfected (n = 19) participants had DTI, laboratory, and 
neuropsychometric performance assessments. DTI metrics were examined using region of interest 
and whole brain voxelwise analyses. Linear mixed-effects models assessed correlations between 
DTI measures and laboratory and neuropsychometric performance values.
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 Results—PHI participants were assessed at a median 4.1 months after estimated infection, and 
had median CD4+ cell count of 573 cells/µl, and HIV-1 RNA viral load of 4.5 log10 copies/ml in 
plasma and 2.6 log10 copies/ml in cerebrospinal fluid (CSF). DTI metrics in PHI individuals were 
similar to HIV— participants and correlated with disruptions in the blood-brain barrier (indicated 
by CSF/plasma albumin ratio and CSF protein). CHI participants had significant loss of white 
matter integrity that correlated with biomarkers of infection and inflammation (blood viral load, 
CD4+ T-cell count, and neopterin, and CSF white blood cell). Within the PHI group, DTI metrics 
inversely correlated with increasing days since infection.
 Conclusion—In individuals assessed during PHI, group DTI measures suggested relative 
preservation of white matter microstructural integrity, but were associated with disruption of the 
blood-brain barrier and estimated duration of infection.
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 Introduction
HIV enters the central nervous system (CNS) soon after initial infection in the form of free 
virions or by way of immune cells travelling across the blood–brain barrier (BBB). Once in 
the brain, HIV targets perivascular macrophages [1] stimulating immune activation. Markers 
of systemic and microglia immune activation are elevated in cerebrospinal fluid (CSF) 
during primary HIV infection (PHI; defined here as ≤1 year after exposure), and remain 
elevated with chronic HIV infection (CHI) (>1 year) [2,3]. Viral and immunopathogenic 
changes that occur during PHI may provide the substrate for subsequent development of 
HIV-associated neurocognitive disorders, including breakdown of the BBB and 
inflammatory changes that facilitate subsequent neurodegeneration in CHI [4]. However, the 
stage at which these alterations occur in the brain due to HIV infection remains poorly 
characterized.
Diffusion tensor imaging (DTI) is a noninvasive MRI technique that can be used to assess 
white matter integrity by quantifying the diffusion of water in the brain [5]. Commonly 
quantified DTI metrics (used here as an umbrella term to include multiple calculated 
measures) are mean diffusivity, the average diffusion in all directions, and fractional 
anisotropy which is a normalized scalar quantity that ranges from zero to one. Higher 
fractional anisotropy values indicate diffusion predominately parallel to axons, likely 
restricted by intact myelin [6]. The corpus callosum, a prominent, homogeneous dense white 
matter tract containing interhemispheric cortical connections, among other white matter 
tracts, has been extensively examined in HIV-infected patients using DTI [7–15]. Most 
commonly, white matter integrity is affected, with HIV-infected individuals having low 
fractional anisotropy and high mean diffusivity when compared with HIV-uninfected 
controls. However, some DTI studies in HIV patients also have shown increases in fractional 
anisotropy [16], an effect that could be due to a loss of transverse fibers in a voxel, leaving 
only parallel tracts to influence anisotropy. Abnormalities in DTI metrics can be improved 
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after the initiation of combination antiretroviral therapy (cART) [12]. To date, most DTI 
studies only have focused on CHI individuals receiving cART.
Changes that can occur in the brain during PHI, including altered white matter integrity, 
have not been well characterized. The few neuroimaging studies that have been performed in 
PHI individuals demonstrated low cerebral blood flow [13], neuroinflammation [14,15,17], 
and reduced brain volume [18]. In this study, we obtained DTI, laboratory measures, and 
neuropsychometric performance from HIV-infected and HIV-uninfected individuals. We 
primarily focused on PHI individuals but included a small cohort of CHI participants to 
probe our methods’ consistency with known DTI characteristics seen with prolonged HIV 
infection. A region of interest (ROI) approach targeting the corpus callosum was employed 
along with an exploratory voxelwise analysis to assess for potential widespread white matter 
changes. DTI metrics were also correlated with laboratory measures and common 
neuropsychometric performance measures. We hypothesized that DTI measures within the 
corpus callosum are affected in PHI and these metrics correlate with measures of BBB 
breakdown and inflammation.
 Materials and methods
 Participants
This study included PHI (n = 62), CHI (n = 16), and HIV-uninfected (n = 19) participants. 
PHI individuals were assessed within 1 year of acquiring HIV as confirmed by a recent 
negative result on HIV antibody testing or ELISA [19]. The date of HIV exposure was 
estimated as 14 days before onset of seroconversion symptoms [20] or as the date halfway 
between the last negative and first positive HIV test [21]. Duration of infection for CHI 
participants was determined by date of first positive HIV test and/or recalled date of 
seroconversion. PHI participants were naive to cART, whereas CHI patients were either 
naive to cART (n = 9) or had elected to stop therapy for at least 3 months before entering 
this study (n = 7, approximate mean time off therapy: 11.7 months). HIV-associated 
neurocognitive disorder (HAND) classification was not determined as only a relatively brief 
testing battery was employed and no measures of functional impairment were obtained. 
HIV-uninfected participants without preexisting medical conditions and with similar age, 
social, and demographic factors to the PHI individuals were recruited from the community; 
they underwent CSF collection for study purposes only. The institutional review board at the 
University of California San Francisco approved the protocol and informed consent was 
obtained from all participants.
 Specimen sampling, processing, and laboratory studies
Clinical examination (including medical and neurological) and laboratory studies (CSF and 
blood) were obtained before neuroimaging [22]. Details of the laboratory analysis have been 
described previously [3]. Blood CD4+ T-lymphocyte counts were measured using flow 
cytometry. Paired blood and CSF samples were analyzed for white blood cell (WBC) count, 
protein, and albumin. Paired cell-free CSF and blood plasma were analyzed for neopterin 
concentrations and HIV RNA viral load. For all comparisons done in this study, clinical and 
laboratory values were grouped into three categories: those representing HIV viral burden 
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(CD4+ T-cell count, plasma viral load, CSF viral load), BBB integrity (CSF protein, CSF/
plasma albumin ratio), and inflammation (plasma neopterin, CSF WBC count, CSF 
neopterin). Although blood TNF-α and interleukin-6 are important markers of systemic 
processes during primary HIV infection, CSF levels of these markers have not been clearly 
shown to predict the development of HIV-associated neurocognitive disorders (HAND). 
Thus, these biomarkers were not examined, as variables for this study focused on CNS 
outcomes in HIV CSF monocyte chemoattractant protein-1 (MCP-1), a measure of 
monocyte/macrophage infiltration in the CNS, was collected in this cohort but the total 
numbers of individuals with both DTI scans and CSF MCP-1 measures were too small to 
pursue in additional analyses for the current study.
 Neuropsychometric performance evaluation
A neuropsychometric performance battery, including timed gait, grooved pegboard, finger 
tapping, and digit-symbol tasks, was administered to participants. All tests, excluding timed 
gait, were standardized according to normative data for age, education, sex, and ethnicity 
and converted to z-scores that were then averaged to calculate a composite 
neuropsychological summary z-score (NPZ-4).
 Neuroimaging acquisition
MRI was performed at the Center for Imaging of Neurodegenerative Diseases of the San 
Francisco Veterans Administration Medical Center using a 4T Siemens/ Bruker MedSpec 
whole-body scanner equipped with a Siemens TRIO console (Siemens AG, Erlangen, 
Germany) and a product transmit/receive 8-channel head coil. A T1-weighted three-
dimensional magnetization-prepared rapid acquisition gradient echo (MPRAGE, TR/T1/TE 
= 2300/950/3 ms, voxel size = 1.0 × 1.0 × 1.0 mm3, flip angle 7°, bandwidth = 200Hz/ pixel) 
was acquired. Four consecutive DTI scans were acquired for each participant to increase 
signal-to-noise (TR/TE = 6000/77 ms, 2.0 × 2.0 × 3.0 mm3 voxels, flip angle 90°, six 
directions, b-values = 0 and 800s/mm2 ).
 Diffusion tensor imaging processing and region of interest analysis
Details of image registration, motion correction, and diffusion tensor estimation for DTI 
metric calculation have been described previously [23,24]. The entire corpus callosum was 
delineated semiautomatically on five midsagittal slices from the fractional anisotropy map of 
each participant using Analyze (Mayo Clinic, Rochester, Minnesota, USA) with a fractional 
anisotropy threshold of 0.3 in an attempt to limit partial volume effects. The sampled corpus 
callosum volume was segmented into five vertical partitions [25] using MATLAB 
(Mathworks, Natick, Massachusetts, USA). These corpus callosum subregions correspond to 
partitions containing inter-hemispheric connections for prefrontal [corpus callosum 1 
(CC1)], premotor and supplementary motor (CC2), primary motor (CC3), primary sensory 
(CC4), and parietal, temporal, and occipital cortices (CC5).
 Voxelwise whole brain analysis of diffusion tensor imaging measures
A voxelwise analysis was performed using the Tract-Based Spatial Statistics (TBSS) 
package (FMRIB, University of Oxford, Oxford, UK) [26,27]. After correcting all images 
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for eddy currents, fractional anisotropy maps were computed using the FMRIB diffusion 
toolbox and aligned to a standard image space using the FMRIB nonlinear image 
registration tool [28]. Calculated DTI metric images were projected onto a mean, group-
dependent fractional anisotropy skeleton (thresholded at fractional anisotropy = 0.3) for 
voxelwise analyses. Group comparisons were performed using FMRIB Randomise, a 
statistical approach that corrects for multiple comparisons using permutation testing [29]. 
Ten thousand permutations were used to estimate the null distributions of each comparison, 
as this number provides a margin of error for P= 0.05 of less than 9% (P= 0.05 ± 0.0044). 
Age was covaried within each group in all correlation analyses.
 Statistical analysis
Demographic characteristics were summarized for the three groups using means and 
standard deviations for the continuous variables and compared among groups using the F-
test of analysis of variance. Mean diffusivity and fractional anisotropy values were log-
transformed or analyzed on the square (power = 2) scale, respectively, to improve normality. 
The three groups were compared with respect to their ROI-specific DTI measures using a 
linear mixed-effects model with a subject-specific random effect and including corpus 
callosum region as a factor. No correction was performed for multiple comparisons for the 
three groups because each pairwise comparison corresponded to different hypotheses done 
at the P = 0.05 level. Additional analyses adjusted for age. However, these analyses should 
be interpreted with caution because older age correlates with CHI categorization in this 
study, and is arguably a mediator of the effect of chronic infection.
The association of DTI metrics with laboratory measures of HIV infection, NPZ-4 score, 
and duration of infection was examined via Pearson’s correlation and simple linear 
regression, separately for the PHI and CHI groups, for each of the five corpus callosum 
regions. The analyses used a Holm-Bonferroni correction for multiple comparisons 
involving the five corpus callosum regions.
 Results
 Participants
Demographic data are shown in Table 1. PHI individuals were assessed at an estimated mean 
4.1 (2.5 SD) months after initial HIV infection. No significant differences existed among 
PHI, CHI, and HIV-uninfected participants with regard to sex, education, and NPZ-4 score, 
plasma viral load, neopterin. CD4+ T-cell count, age, and all CSF measures differed among 
groups (all P < 0.05).
 Diffusion tensor imaging metrics of white matter integrity are affected in chronic HIV 
infection but not in early primary HIV infection
We focused our initial attention on the corpus callosum as this region is a prominent white 
matter tract responsible for interhemispheric communication and has been shown to be 
affected by HIV [6,8–10,30]. In general, PHI and HIV-uninfected groups had comparable 
values, whereas CHI patients had substantial differences in DTI metrics across all corpus 
callosum subregions compared with the other groups. For mean diffusivity and fractional 
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anisotropy, pairwise comparisons across corpus callosum subregions demonstrated no 
significant differences between HIV-uninfected and PHI groups (mean diffusivity: P = 0.59, 
fractional anisotropy: P = 0.84), but both metrics were higher in CHI compared with PHI 
and HIV-uninfected (mean diffusivity: both P < 0.05, fractional anisotropy: both P < 0.001) 
(Fig. 1a and b). These relationships were maintained throughout cerebral white matter using 
whole brain voxelwise comparisons (Fig. 1c and d).
 Correlations between diffusion tensor imaging metrics and laboratory measures of HIV 
infection in primary HIV infection and chronic HIV infection
The correlations of fractional anisotropy and mean diffusivity with laboratory markers for 
PHI and CHI from all corpus callosum regions are tabulated in Supplemental Digital 
Content 1 (Table http://links.lww.com/QAD/A622). In brief, for the PHI participants, DTI 
metrics in CC2 and CC3 showed correlations with markers typically associated with 
disruption of the BBB (e.g., CSF/plasma albumin ratio and CSF protein) and plasma viral 
load, but not measures of inflammation. The albumin ratio and CSF protein measures were 
also highly correlated (Spearman’s ρ = 0.93), consistent with their shared putative roles as 
biomarkers of BBB integrity. NPZ-4 performance did not correlate with DTI metrics from 
any corpus callosum region in the PHI group (Fig. 2a – f).
DTI metrics in CHI correlated with markers of HIV viral burden (e.g. blood CD4+ T-cell 
count and viral load) as well as indicators of cellular activation (e.g. plasma neopterin and 
CSF WBC), but not BBB integrity, using an ROI analysis. In the CHI group, NPZ-4 
performance correlated with DTI metrics in CC2 (P = 0.004), CC3 (P = 0.017), and CC4 (P 
= 0.031) (Fig. 2). These regions in particular contain tracts connecting motor regions that are 
likely the most implicated in our psychomotor NPZ-4 battery, providing further validation of 
the sensitivity of our corpus callosum segmentation and sampling methods. Data for CC1 
and CC5 are not shown because they were not significantly implicated using our 
neuropsychological battery.
Voxelwise comparisons further supported the relationships between DTI metrics and 
laboratory values observed in the ROI analysis, with the CHI group showing more pervasive 
effects (Fig. 3a and b). Moreover, mean diffusivity from CHI participants showed 
correlations with both plasma viral load and CSF viral load (data not shown). For PHI 
individuals, fractional anisotropy in the body of the corpus callosum correlated with plasma 
viral load (data not shown) and CD4+ T-cell count correlated with fractional anisotropy in 
the anterior half of the corpus callosum. In the CHI group, fractional anisotropy in the 
anterior white matter tracts correlated with plasma viral load. Although no significant 
correlations were observed in the corpus callosum ROI analysis between CHI and CSF/
protein albumin ratio, other white matter regions showed a relationship. It is possible that 
duration of infection dependence exists within this affected location. Importantly, the 
voxelwise analysis showed a strong correlation between both mean diffusivity and fractional 
anisotropy with plasma neopterin in the anterior portion of the corpus callosum of CHI 
participants. This effect was also supported by our ROI analysis, providing additional 
agreement between the two methods. Significant relationships were based on correlations in 
expected directions (e.g. CHI fractional anisotropy and viral load were inversely correlated).
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 Diffusion tensor imaging metrics correlate with duration of HIV infection in the corpus 
callosum
We also analyzed HIV duration of infection as a function of DTI metrics. Within the PHI 
group alone, a significant relationship between fractional anisotropy and duration of 
infection was seen exclusively within CC1 (semipartial correlation R= −0.284 (controlling 
for age, P = 0.028) (Fig. 4a and b). When the PHI and CHI participants were merged into a 
single group, an effect of duration of infection (plotted on a log2 scale) was observed for 
mean diffusivity [semipartial correlation R = 0.350 (controlling for age), P = 0.002] and 
fractional anisotropy (semipartial correlation R= −0.426 (controlling for age), P ≤ 0.001) 
(Fig. 4a and b). Only fractional anisotropy and mean diffusivity from CC1 showed such a 
strong relationship with duration of infection (data not shown for CC2–CC5). These results 
imply that there is a continuous effect of time detectable within the range of durations of 
infection in this cohort.
 Discussion
We show that white matter integrity as measured by DTI is not altered in a group of PHI 
participants (mean: 4.1 months after infection). However, white matter integrity is 
significantly altered in an untreated CHI group (mean: 11.3 years since diagnosis). Our 
results in this small CHI cohort are similar to previous reports of treated and untreated CHI 
participants that demonstrated a reduction in fractional anisotropy and an increase in mean 
diffusivity [12]. In our study, observed changes in DTI metrics correlated more strongly with 
laboratory values for CHI rather than PHI participants. When looking at the continuum of 
HIV infection, a negative correlation was observed between DTI metrics and increasing 
duration of infection, even within the first year of infection. Our findings suggest that HIV is 
associated with changes in white matter integrity soon after infection and these changes 
become more readily apparent with prolonged infection. These results also suggest the 
potential utility of DTI to assess HIV-related disorder noninvasively.
Comparisons of DTI metrics with CSF and blood biomarkers may begin to provide us a 
timeline for mechanisms of white matter injury initiated during early HIV infection. Within 
the PHI group, markers of BBB breakdown (CSF/plasma albumin ratio and CSF protein) 
correlated with DTI metrics, but it is interesting that we actually did not observe any 
significant differences in DTI metrics between the large group of PHI participants and the 
HIV-uninfected participants, despite the previously (well characterized) observed effects in 
CHI using DTI [8–14]. However, when we analyzed with respect to duration of infection, we 
did observe changes in fractional anisotropy relatively early after seroconversion. It may be 
that arbitrary grouping using a cutoff of less than 1 year duration of HIV may miss 
progressive changes. It is possible that the observed results reflect the existence of a biphasic 
model of white matter degradation in which alterations are due to different HIV-dependent 
mechanisms depending on the current stage of infection. Specifically, during PHI, increased 
BBB permeability may drive observed white matter changes, whereas the mechanisms 
underlying continued alterations observed at later times shift from a dependence on BBB 
integrity to ongoing chronic cell-mediated inflammation. Larger group sizes and 
longitudinal analyses are needed to support this hypothesized model.
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Within the small CHI cohort, markers of inflammation (neopterin and immune cells in the 
blood and CSF, respectively) correlated with DTI metrics. Activation of both infected and 
uninfected macrophages and microglia in the brain could propagate inflammation and edema 
and influence DTI measures. In particular, a greater abundance of inflammatory cells seen in 
CHI, as well as surrounding debris, could affect the free path of water diffusion and lead to 
changes in both fractional anisotropy and mean diffusivity [31,32]. Cloak et al. [33] showed 
a strong correlation between frontal white matter mean diffusivity and myoinositol, a glial 
metabolite. These findings imply that increased diffusion may reflect increased glial 
activation or inflammation. We observed significantly higher radial diffusivity in CHI than 
both PHI and HIV-uninfected controls (data not shown). This effect may reflect 
inflammatory vasogenic edema rather than localized myelin degradation [34,35].
This study has several limitations. The focus of this study, unlike many others, was to study 
potential early changes in white matter brain integrity of PHI. Relatively fewer numbers of 
CHI and HIV-uninfected participants were recruited compared with PHI individuals, thus 
reducing statistical power to detect significant differences between groups. Because of the 
cross-sectional nature of this study, we are unable to comment on the within-participant 
effect of HIV progression over time. Future studies that assess PHI participants 
longitudinally are needed to fully characterize the effects of HIV infection on cerebral white 
matter during this time and to subsequently determine the optimal time for initiating cART 
(as we chose to examine the effects of HIV itself without influence of therapy). Furthermore, 
duration since diagnosis in the CHI participants was obtained by self-report and has 
potential recall bias and might be distant from actual time of HIV acquisition. We 
considered the laboratory-confirmed PHI disease duration to be critical to the analysis, 
whereas the less precise estimated CHI durations were valuable even if they underestimated 
actual length of infection. Also, the ROI and TBSS methods were largely in agreement, but 
differences may arise because of the different processing streams used as well as the 
relatively narrow volume sampled from the corpus callosum in the ROI analysis. Although 
mean age differed between HIV-infected groups (PHI: 36.9 years old, CHI: 45.1 years old), 
previous studies of DTI changes in healthy aging have reported significant age-dependent 
alterations in time windows usually spanning a minimum of 20 years [36]. We did not 
consider the effects of other potential comorbidities (e.g. alcohol and methamphetamine 
abuse, smoking, hepatitis coinfection, etc.) that have been implicated in changes in brain 
structure and function in HIV-infected individuals. Although outside of the scope of this 
study, it will be important to examine the impact of these factors in PHI. Finally, although 
the correlation coefficients for the significant associations observed between callosal DTI 
metrics and duration of infection and clinical measures within the PHI group were less than 
0.5, we believe they are critical to report as they may point to the mechanisms of early HIV 
pathophysiology in the brain.
 Conclusion
In summary, DTI metrics that reflect white matter integrity were not abnormal in this study 
of early PHI, but they correlated with markers of BBB breakdown. Moreover, fractional 
anisotropy decreased as a function of duration of infection within the first year of infection. 
In contrast, DTI metrics from CHI participants correlated strongly with clinical markers of 
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inflammation and disease progression. The strong relationship between fractional anisotropy 
from the PHI group and duration of infection existing at the cross-sectional level supports 
pursuing longitudinal analysis to elucidate further the relationship between duration of HIV 
infection and its neurodegenerative capacity. These data provide further evidence of the 
utility of DTI metrics as noninvasive biomarkers of white matter change in HIV infection, 
and they emphasize the importance of diagnosing HIV soon after infection to possibly 
preempt further neuropathology through early treatment.
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Fig. 1. Groupwise region of interest and voxelwise comparisons of mean diffusivity and fractional 
anisotropy
Five vertical partitions from the corpus callosum were sampled using an ROI analysis for 
both mean diffusivity (a) and fractional anisotropy (b). CHI participants had substantial 
differences in DTI metrics compared with other groups, whereas PHI and HIV-uninfected 
(HIV-) had comparable values. Horizontal line: group mean. Whiskers extend to either 1.5Q 
below Q1 or 1.5Q above Q3. (c) Voxelwise comparisons of mean diffusivity for (starting 
from top): CHI>HIV–, CHI>PHI, PHI>HIV–. (d) Comparisons of fractional anisotropy for 
(starting from top): CHI<HIV– CHI<PHI, PHI<HIV–. Only CHI, not PHI, showed 
significant changes in mean diffusivity and fractional anisotropy relative to HIV-uninfected 
participants in the anterior forceps, optic radiations, and other white matter tracts. Red: 
P=0.05; Orange: P= 0.03; Yellow: P= 0.01. CC, corpus callosum; CHI, chronic HIV 
infection; FA, fractional anisotropy; MD, mean diffusivity; PHI, primary HIV infection.
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Fig. 2. Relationship between fractional anisotropy and mean diffusivity and neuropsychological 
performance, average z- score from four tests
(a and b) Mean diffusivity and fractional anisotropy from CC2 correlated with NPZ-4. (c and 
d) Mean diffusivity and fractional anisotropy from CC3 correlated with NPZ-4. (e and f) 
Mean diffusivity and fractional anisotropy from CC4 correlated with NPZ-4. *P < 0.05. 
Fractional anisotropy from CC2-CC4 from the CHI group significantly correlated with 
neuropsychometric performance, the regions expected to be implicated by our psychomotor 
battery. NPZ-4 data were missing from four PHI and six CHI participants. Solid line: Best-
fit line for PHI group. Dashed line: Best-fit line for CHI group. CC2-4, corpus callosum 2–4; 
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CHI, chronic HIV infection; FA, fractional anisotropy; MD, mean diffusivity; NPZ-4, 
neuropsychological performance, average z-score from four tests; PHI, primary HIV 
infection.
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Fig. 3. Voxelwise correlations between mean diffusivity (a) and fractional anisotropy (b) from 
primary HIV infection and chronic HIV infection with plasma neopterin, CD4+ T-cell count, and 
cerebrospinal fluid/plasma albumin ratio
CHI patients showed pervasive correlations with laboratory measures. White matter changes 
in the PHI group correlated with CD4+ T-cell count (b, second row) and plasma viral load 
(data not shown). Red: P = 0.05; Orange: P = 0.03; Yellow: P = 0.01. CHI, chronic HIV 
infection; CSF, cerebrospinal fluid; FA, fractional anisotropy; MD, mean diffusivity; PHI, 
primary HIV infection.
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Fig. 4. Effect of duration of infection on mean diffusivity (a) and fractional anisotropy (b) in CC1
Both HIV-infected groups (PHI and CHI) are plotted as function of duration of infection. 
The time dependence (x-axis) is linear on the log2 scale. The regression line, 95% 
confidence intervals, and P value are included for the PHI group (solid line and shaded P 
value) and a regression line is included for the combined HIV-infected group (dashed line 
and top right P value). Both fractional anisotropy from the PHI group as well as both 
fractional anisotropy and mean diffusivity from a combined HIV-infected group (from CC1) 
showed significant correlation with duration of infection. CC1, corpus callosum 1; CHI, 
chronic HIV infection; FA, fractional anisotropy; MD, mean diffusivity; PHI, primary HIV 
infection.
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Table 1
Demographic and clinical information for the study participants.
HIV– PHI CHI Pa
Sample size (n) 19 62 16
Age (years) 34.5 (9.9) 36.9 (9.1) 45.1 (10.3) 0.003
Sex (men/n) 19/19 62/62 15/16 0.17
Education (years) 16.1 (2.6) 15.4 (2.2) 14.3 (2.3) 0.083
Duration of infectionb (months) 4.1 (2.5) 138.1 (96.9) <0.001
NPZ-4 −0.4 (0.9) 0.0 (0.7) 0.0 (0.6) 0.21
CD4+ T-cell count 790 (745, 1003) 573 (410, 748) 223 (145, 310) <0.001
Plasma HIV-1 viral load (log10) 4.5 (3.9, 5.0) 4.6 (4.2, 5.0) 0.43
CSF HIV-1 viral load (log10) 2.6 (1.7,3.1) 4.1 (3.2,4.4) <0.001
Plasma neopterin 17.1 (16.4) 20.6 (13.6) 0.55
CSF neopterin 12.9 (12.4) 36.7 (27.9) <0.001
CSF white blood cell count 1.8 (1.5) 8.5 (9.9) 8.3 (6.8) 0.033
CSF protein 36.6 (8.8) 41.1 (13.3) 59.8 (18.9) <0.001
CSF/Plasma albumin ratio 5.3 (1.9) 5.5 (2.3) 7.6 (3.5) 0.013
Mean (SD) or median (Q1, Q3) is shown. CHI, chronic HIV infection; CSF, cerebrospinal fluid; NPZ-4, neuropsychological performance, average 
z-score from 4 tests; PHI, primary HIV infection.
a
P values reported for parameters possessed by all three groups are determined using analysis of variance for comparison across all groups.
b
For PHI, duration of infection was estimated by date of recent seroconversion as confirmed by laboratory measures. CHI duration of infection 
reflected the period since known HIV diagnosis.
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